|
| Press Releases |
|
 |
|
| Thursday, June 2, 2022 |
|
|
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares |
| On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to the agreement, Vivo Suzhou Fund and Centerlab agreed to subscribe for 116,250,000 and 33,750,000 shares of TOT BIOPHARM more info >> |
|
| Wednesday, June 1, 2022 |
|
|
维梧苏州基金及晟德大药厂认购东曜药业股份 |
| 东曜药业（股票代码：1875.HK）宣布公司与维梧苏州基金及晟德大药厂订立股份认购协议。根据协议，维梧苏州基金与晟德大药厂将分别认购东曜药业配售股份116,250,000股及33,750,000股，认购价每股 3.15港元（依据过往5个交易日溢价发行），合共150,000,000股，占本公告日期公司已发行股本约24.38%。 more info >> |
|
|
維梧蘇州基金及晟德大藥廠認購東曜藥業股份 |
| 東曜藥業（股票代碼：1875.HK）宣佈公司與維梧蘇州基金及晟德大藥廠訂立股份認購協議。根據協議，維梧蘇州基金與晟德大藥廠將分別認購東曜藥業配售股份116,250,000股及33,750,000股，認購價每股 3.15港元（依據過往5個交易日溢價發行），合共150,000,000股，占本公告日期公司已發行股本約24.38%。 more info >> |
|
|
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares |
| TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement with VIVO Suzhou Fund and Centerlab. Pursuant to the agreement, Vivo Suzhou Fund and Centerlab agreed to subscribe for 116,250,000 and 33,750,000 shares of TOT BIOPHARM more info >> |
|
| Friday, August 13, 2021 |
|
|
東曜藥業2021年中期營業收入大幅增長78%至人民幣2,313萬元 |
| 東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）－ 專注於創新型腫瘤藥物及療法開發和商業化的生物製藥公司，今天欣然宣佈其截至2021年6月30日止6個月未經審核中期業績。 more info >> |
|
|
TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Group"; stock code: 1875.HK), a biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its unaudited interim results for the six months ended 30 June 2021. more info >> |
|
| Wednesday, March 24, 2021 |
|
|
東曜藥業宣佈2020年多項重點抗腫瘤藥物進入關鍵臨床階段 |
東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）－ 專注於創新型腫瘤藥物及療法的臨床階段生物製藥公司，今天欣然宣佈其截至2020年12月31日止年度（「年內」）之經審核全年業績。
more info >> |
|
|
TOT BIOPHARM Announces A Number of Key Anti-Tumor Drugs Have Entered the Pivotal Clinical Stage in 2020 |
| TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK), a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies, announced today its audited annual results for the year ended 31 December 2020. more info >> |
|
| Friday, October 16, 2020 |
|
|
东曜药业股份有限公司完善公司管理架构 推动战略发展升级 |
东曜药业股份有限公司（「东曜药业」或「公司」；股票代码：1875.HK）今日欣然宣布委任执行董事黄纯莹女士（「黄女士」）为董事会副主席，辞任总经理一职；同时宣布委任执行董事兼首席科学官刘军博士（「刘博士」）为公司首席执行官，并不再兼任首席运营官及副总经理职务。
more info >> |
|
|
東曜藥業股份有限公司完善公司管理架構 推動戰略發展升級 |
| 東曜藥業股份有限公司（「東曜藥業」或「公司」；股票代碼：1875.HK）今日欣然宣佈委任執行董事黃純瑩女士（「黃女士」）為董事會副主席，辭任總經理一職；同時宣佈委任執行董事兼首席科學官劉軍博士（「劉博士」）為公司首席執行官，並不再兼任首席運營官及副總經理職務。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 14:34: JST
|
|
|
スパークス・グループによる「宇宙フロンティア2号ファンド」の設立について
Apr 26, 2024 14:00: JST
|
|
|
中滙集團公佈2024財年中期業績
Apr 26, 2024 13:51 HKT/SGT
|
|
|
Edvantage Group Announces FY2024 Interim Results
Apr 26, 2024 13:43 HKT/SGT
|
|
|
Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project
Apr 26, 2024 13:27 HKT/SGT
|
|
|
Imexpharm Corporation Hosts Shareholders, Analysts and Potential Investors at its 2024 Annual General Meeting
Apr 26, 2024 13:16 HKT/SGT
|
|
|
UK advertising reports GBP36.6bn spend in 2023
Apr 26, 2024 11:00 HKT/SGT
|
|
|
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 10:00 JST
|
|
|
Jeff Martin Auctioneers to Manage Sale of Sabine Mining Company Assets for North American Coal
Apr 26, 2024 08:00 HKT/SGT
|
|
|
Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase
Apr 25, 2024 21:00 HKT/SGT
|
|
|
黑桃资本向香港红十字会捐赠艺术珠宝收藏品
Apr 25, 2024 20:53 HKT/SGT
|
|
|
黑桃資本向香港紅十字會捐贈藝術珠寶收藏品
Apr 25, 2024 20:48 HKT/SGT
|
|
|
Black Spade Donates Art and Jewellery Collection To Hong Kong Red Cross
Apr 25, 2024 20:40 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2023 Inaugural Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
Apr 25, 2024 19:09 HKT/SGT
|
|
|
【最新弹床好去处推介】将军澳中心x Kiztopia星际弹游太空站
Apr 25, 2024 18:05 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
